Skip to content
Home/Companies/Biotech/Oloker Therapeutics
Oloker Therapeutics

Oloker Therapeutics

Biotech·Italy·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Oloker Therapeutics?

Oloker Therapeutics is currently owned by Siryo through Siryo S.p.A. (2019 vintage), since 2021.

Hand-verified · updated 2026-08-02

Siryo
Investor
Siryo
Siryo S.p.A. · 2019 · VC

Key facts

HQItaly
SectorBiotech
StatusActive
Websitewww.oloker.com

More from Siryo S.p.A.

Other portfolio companies in the same fund.

EggPlant
Active
ClimateTechItaly· 2023
Oxoco
Active
ClimateTechItaly· 2021
Postbiotica
Postbiotica
Active
BiotechItaly· 2021
Votis
Votis
Active
MedTechIsrael· 2021
Celery
Celery
Active
FoodTechItaly· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Oloker Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Oloker Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue